FDA
-
-
-
-
-
-
-
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of
-
-
-
-
-
-
-
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
-
-
-
-
-
-
-
Nexalin highlights peer-reviewed research on brain stimulation technology
-
-
-
-
-
-
-
Nexalin (NXL) enrolls first patients in trial for Nexalin HALO
-
-
-
-
-
-
-
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
-
-
322,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

